Navigation Links
Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
Date:6/7/2009

Improvements in Systolic Blood Pressure and Triglycerides Also Observed

NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY), and Alkermes, Inc. (Nasdaq: ALKS) today announced long-term, interim results from the DURATION-1 study that showed sustained glucose control with weight loss, as well as improvements in systolic blood pressure and triglycerides, through two years of treatment with exenatide once weekly, an investigational therapy for type 2 diabetes. These findings were presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) in New Orleans. A New Drug Application (NDA) for exenatide once weekly was recently submitted to the U.S. Food and Drug Administration.

In the controlled portion of the open-label study, patients received exenatide once weekly or BYETTA(R) (exenatide) injection for 30 weeks, followed by 74 weeks of treatment with exenatide once weekly for all patients during an open-ended assessment period. Significant reductions in A1C of 1.7 percent and fasting plasma glucose (FPG) of 40 mg/dL were maintained after two years of treatment. Sixty-five percent of patients achieved an A1C of 7 percent or less. A1C of less than 7 percent is the target for good glucose control as recommended by the ADA. Body weight was significantly reduced, with patients losing an average of 5.8 pounds. Serum lipid profiles were significantly improved, and there was a significant reduction in systolic blood pressure (SBP).

"These two-year DURATION-1 data showed that maintenance of steady state concentrations of exenatide may res
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
2. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
3. Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
4. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
5. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
6. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
7. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
8. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
9. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 6, 2015  Law office of Brodsky & ... claims against the Board of Directors of Pharmacylics, ... breaches of fiduciary duty and other violations of ... the Company to AbbVie, Inc. ("AbbVie") ... http://brodsky-smith.com/900-pcyc-pharmacyclics-inc.html , or call: 877-534-2590. There is ...
(Date:3/6/2015)... LAKE FOREST, Ill. , March 6, 2015   ... and the U.S. Food and Drug Administration (FDA) on today,s ... United States . This is a watershed moment for ... medicines. As a leading global provider of biosimilars, Hospira has ... and we are a proud participant in these early stages ...
(Date:3/6/2015)... 6, 2015  Abaxis, Inc. (NasdaqGS: ABAX ... consumables for the medical, research, and veterinary markets worldwide ... research markets in the United States ... of the U.S. Department of Agriculture (USDA) has cleared ... of   A. phagocytophelium and A. platys ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Pharmacyclics, Inc. - PCYC 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 3
... SALT LAKE CITY, Feb. 28, 2011 Concentra, a ... is transforming the future of occupational and urgent care ... and engaging experiences for clients and patients. Recent customer ... the ranks of top U.S. consumer companies as a ...
... 2011 caprotec bioanalytics GmbH announced today ... of three core patents protecting its proprietary and revolutionary ... CCMS offers a novel and direct way to investigate ... functional reduction of proteome complexity. The core of the ...
Cached Medicine Technology:Concentra is Writing a New Prescription on Health Care With Outstanding Service 2Concentra is Writing a New Prescription on Health Care With Outstanding Service 3Concentra is Writing a New Prescription on Health Care With Outstanding Service 4Concentra is Writing a New Prescription on Health Care With Outstanding Service 5caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology 2
(Date:3/6/2015)... CHICAGO (PRWEB) March 06, 2015 As ... and healthcare services programs, the organization has hired two ... Hagerty, Ph.D. They will report to Grace Pavlath, ... Vice President and Scientific Program Director, and together will ... lead to treatments and cures for various types of ...
(Date:3/6/2015)... Parents need to start the discourse ... use disorders. School programs like DARE, or Drug Abuse ... or Narcotics Overdose Prevention and Education has already impacted ... News on Feb. 27th. As teens continue to ... drug prevention proponents are lobbying Florida to pass The ...
(Date:3/6/2015)... Anaheim, Cailfornia (PRWEB) March 06, 2015 ... lifestyle technology company, announced today the launch of ... save money on healthy and sustainable products at ... retailers. Makeena is exhibiting at Expo West Booth ... to search by gluten-free, Kosher, non-GMO, organic, Paleo, ...
(Date:3/6/2015)... 06, 2015 Since Medicare began paying ... there has been an overwhelming demand from providers for ... compliant CCM program. The Centers for Medicare & ... , PYA’s updated white paper—“ Providing and Billing ... into a detailed, yet practical “how to” manual for ...
(Date:3/6/2015)... Atlanta, GA (PRWEB) March 06, 2015 ... algorithms, announced the release of a Clostridium Difficile ... outpatient providers. The C Diff use case is ... capabilities that span hospital acquired infections, chronic conditions, ... phenotype platform, the C Diff solution flags at ...
Breaking Medicine News(10 mins):Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... The bottom-line message from a decades-long study of monkeys ... leads to a longer, healthier life. Writing today ... team of researchers at the University of Wisconsin-Madison, the ... Middleton Memorial Veterans Hospital reports that a nutritious but ...
... July 9 Connectyx (Other OTC: CTYX) - Connectyx Technologies ... hosting a Nationwide Teleconference today, July 9, 2009, at 4:15pm ... Schuman, Connectyx President and CEO will update shareholders and the ... Company has developed over the last six months, its initiatives ...
... 9 Emergency information is just one touch away with ... application for the Apple iPhone. , , This is ... to review first aid procedures, anytime, anywhere. First aid instructions ... , Powered by Jive Media, the application is available for ...
... Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), ... tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring ... M.D., Chairman and Chief Executive Officer, will present at the ... 5:30 pm ET. The presentation will occur live and ...
... to grow in popularity, injuries to soccer players are ... into gender-based patterns and new research at Hospital for ... lead to better treatment, or even prevention for present ... year,s American Orthopaedic Society for Sports Medicine meeting in ...
... Ga., July 9 Immucor, Inc. (Nasdaq: BLUD ... the blood transfusion industry, today announced that it will release ... after the market close. The Company will host a conference ... time) to discuss the results. , , ...
Cached Medicine News:Health News:Reduced diet thwarts aging, disease in monkeys 2Health News:Reduced diet thwarts aging, disease in monkeys 3Health News:Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference Today, July 9, 2009; Company Will Discuss Recent Developments, New Partnerships and Initiatives for MedFlash EPHR, and Second Quarter Results 2Health News:American Heart Association Launches First iPhone Application: First Aid and CPR Information Within Pocket's Reach 2Health News:Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference 2Health News:Echo Therapeutics To Present at Prestigious 'Innovations in Diabetes' Conference 3Health News:Motion analysis helps soccer players get their kicks 2Health News:Motion analysis helps soccer players get their kicks 3
... Chrono-log's wide range of Platelet aggregometers ... to meet particular needs. Single, dual ... with chart recorder outputs or digital ... Chrono-log Optical aggregometers, which measure platelet ...
... a four channel platelet aggregation profiler combined ... in conjunction with Microsoft WindowsTM, the PAP-4CD ... tests, automatic storage of test results, plus ... test modes are available: chromogenic assays, von ...
... is a four channel platelet aggregation profiler ... assays, von Willebrand assay (Ristocetin cofactor), platelet ... also be used for the evaluation and ... channels allow four tests to be run ...
... plus, innovation means 4 on-board measurement ... and im-proved operator ergonomics. This supports ... required for true workload consolidation, leading ... only one analytical platform, one user ...
Medicine Products: